Celsion sponsors trial for prostate cancer therapy:
This article was originally published in Clinica
The University of California at San Francisco (UCSF) has begun a preclinical evaluation of Celsion's microwave-based prostate cancer treatment system, with sponsorship from the company. The system combines focused heat, delivered by microwaves, together with radiation seed implant therapy. Dr Mack Roach, associate professor of radiation therapy at UCSF said: "It is well known that thermotherapy can increase the effectiveness of radiation by a factor of up to two times."
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.